REPARE THERAPEUTICS INC (RPTX) Forecast, Price Target & Analyst Ratings

NASDAQ:RPTX • US7602731025

Current stock price

2.65 USD
+0.02 (+0.76%)
At close:
2.65 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for REPARE THERAPEUTICS INC (RPTX).

Forecast Snapshot

Consensus Price Target

Price Target
$3.06
+ 15.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$0.43
Revenue Estimate
2.55M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.06
Upside
+ 15.47%
From current price of $2.65 to mean target of $3.06, Based on 8 analyst forecasts
Low
$3.03
Median
$3.06
High
$3.15

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for RPTX. The average price target is 3.06 USD. This implies a price increase of 15.47% is expected in the next year compared to the current price of 2.65.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RPTX Current Analyst RatingRPTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

RPTX Historical Analyst RatingsRPTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
RPTX was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about RPTX.
In the previous month the buy percentage consensus was at a similar level.
RPTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-27HC Wainwright & Co.Maintains Buy -> Buy
2025-03-07HC Wainwright & Co.Maintains Buy -> Buy
2024-12-13LifeSci CapitalDowngrade Outperform -> Market Perform
2024-12-13StifelMaintains Buy -> Buy
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-24HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-05HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-14HC Wainwright & Co.Maintains Buy -> Buy
2023-11-20HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-16Piper SandlerMaintains Overweight -> Overweight
2023-09-25StifelMaintains Buy -> Buy
2023-08-17HC Wainwright & Co.Maintains Buy -> Buy
2023-06-09StifelUpgrade Hold -> Buy
2023-06-09HC Wainwright & Co.Maintains Buy -> Buy
2023-04-27HC Wainwright & Co.Reiterate Buy
2023-03-17HC Wainwright & Co.Reiterate Buy
2023-02-27Morgan StanleyMaintains Equal-Weight
2023-02-03Morgan StanleyDowngrade Overweight -> Equal-Weight
2022-11-17HC Wainwright & Co.Maintains Buy
2022-08-08Morgan StanleyMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$0.43
Revenue Estimate
2.55M
Revenue Q2Q
N/A
EPS Q2Q
36.06%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-83.41%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
RPTX revenue by date.RPTX revenue by date.
131.8M
1,634.21%		51.133M
-61.20%		53.477M
4.58%		306K
-99.43%		6.8M
2,122.22%
-100.00%
EBITDA
YoY % growth
RPTX ebitda by date.RPTX ebitda by date.
-17.82M
83.38%		-114.273M
-541.26%		-90.223M
21.05%		-85.854M
4.84%		-91.451M
-6.52%		N/AN/AN/AN/A
EBIT
YoY % growth
RPTX ebit by date.RPTX ebit by date.
-19.8M
81.78%		-116.224M
-486.99%		-92.144M
20.72%		-99.068M
-7.51%		-32.028M
67.67%		-25.5M
20.38%		-26.52M
-4.00%		-27.54M
-3.85%		-28.56M
-3.70%
Operating Margin
RPTX operating margin by date.RPTX operating margin by date.
-15.02%-227.30%-172.31%-32,375.00%-471.00%N/AN/AN/AN/A
EPS
YoY % growth
RPTX eps by date.RPTX eps by date.
-0.78
72.34%		-2.23
-185.90%		-2.00
10.31%		-2.15
-7.61%		-0.74
65.40%		-0.61
17.81%		-0.29
53.33%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth		-0.43
36.06%		-0.29
53.37%		-0.17
62.21%		-0.14
-457.00%
Revenue
Q2Q % growth		2.55M1.7M1.7M1.7M
-85.37%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.073M
34.82%		-12.648M
54.70%		-7.14M
64.41%		-6.12M
-1,323.26%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RPTX Yearly Revenue VS EstimatesRPTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
RPTX Yearly EPS VS EstimatesRPTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.21%
EPS Next 5 Year
16.74%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

REPARE THERAPEUTICS INC / RPTX Forecast FAQ

What is the average price target for REPARE THERAPEUTICS INC (RPTX) stock?

8 analysts have analysed RPTX and the average price target is 3.06 USD. This implies a price increase of 15.47% is expected in the next year compared to the current price of 2.65.

Can you provide the consensus estimates for REPARE THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of REPARE THERAPEUTICS INC (RPTX) is -0.43 USD and the consensus revenue estimate is 2.55M USD.

Can you provide the expected long term growth rate for REPARE THERAPEUTICS INC stock?

The expected long term growth rate for REPARE THERAPEUTICS INC (RPTX) is -25.99%.